Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 3 recruiting now small index

Muscle Loss clinical trials

3 of 7 indexed Muscle Loss trials are currently recruiting.

Corpus placement: #2,497 of 28,707 conditions by registered trial count.

7 US clinical trials · 3 currently recruiting · #2,497 of 28,707 conditions by registered trial count

Muscle Loss: 7 US clinical trials tracked, 3 recruiting.

Muscle Loss is the subject of 7 registered US clinical trials on ClinicalTrials.gov, 3 of them currently open to new participants. The most active sponsor is Impactiv, running 1 of these trials.

Enrollment posture brief

Registry condition muscle-loss

OPEN 3 | RECR 43% | LATE 0 | EARLY 0 | RANK #2497 | SPON 1

Nearest open-share peer: Adrenoleukodystrophy (43% recruiting · 7 trials)

ACL Tear71.4%ACL57.1%Muscle Loss (this)43%Acute Myelogenous Leukemia42.9%Acne Scars28.6%
Open-enrollment share among volume-matched conditions near Muscle Loss

Muscle Loss lists 3 open slots (43% of 7 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Muscle Loss on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Muscle Loss is recruiting below its size-band peers.

    3 of 7 indexed trials (42.9%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. Sponsorship of Muscle Loss trials is spread across many organizations.

    Impactiv accounts for 1 of 7 trials (14.3%). 7 distinct sponsors appear on at least one study for this condition label.

  3. Most Muscle Loss trials plan to enrol fewer than 100 people.

    Median target enrolment is 74 among the 7 trials that report a genuine target (sentinel values excluded). 5 of those (71.4%) plan for fewer than 100 participants.

  4. Muscle Loss research is mostly interventional.

    6 interventional and 1 observational studies make up this index (85.7% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase Distribution

Phase data not available

Named interventions

Most-linked intervention names on Muscle Loss records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

maltodextrin powder Other
1 trials
microcrystalline cellulose Other
1 trials
potassium bicarbonate (KHCO3) Dietary supplement
1 trials
whey protein isolate Dietary supplement
1 trials
Dietary Protein Intake Other
1 trials
Vivo Behavioral
1 trials
Cftr Modulators Drug
1 trials
LiverWatch Intervention Behavioral
1 trials

US sites by state

Facility locations filed on Muscle Loss trials. A trial with sites in several states counts in each.

Massachusetts 2 trials
Pennsylvania 1 trials
New Jersey 1 trials
North Dakota 1 trials
North Carolina 1 trials
Michigan 1 trials
Maryland 1 trials
Indiana 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Muscle Loss page

7 registered trials, 3 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 3 Muscle Loss trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • Impactiv sponsors the most Muscle Loss trials on record, review their full trial history before evaluating a specific study. See Impactiv's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Muscle Loss condition card totals 7 registered trials; most-linked intervention maltodextrin powder; top US site state Massachusetts. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.